Featured Research

from universities, journals, and other organizations

One species, two outcomes: Team seeks source of body louse pathology

Date:
January 10, 2014
Source:
University of Illinois at Urbana-Champaign
Summary:
A new study seeks to determine how one parasitic species can give rise to two drastically different outcomes in its host: The human body louse (Pediculus humanus) can transmit dangerous bacterial infections to humans, while the human head louse (also Pediculus humanus) does not.

The human head louse, left, and body louse, right, are the same species, but differ in their ability to transmit disease to their host. Researchers now think they know why.
Credit: Centers for Disease Control and Prevention

A new study seeks to determine how one parasitic species can give rise to two drastically different outcomes in its host: The human body louse (Pediculus humanus) can transmit dangerous bacterial infections to humans, while the human head louse (also Pediculus humanus) does not.

A report of the new study appears in the journal Insect Molecular Biology.

"Body louse-transmitted diseases include trench fever, relapsing fever and epidemic typhus," said University of Illinois entomology professor Barry Pittendrigh, who led the research. In a previous study, Pittendrigh and his colleagues compared the sequences of all protein-coding genes in head and body lice and determined that the two belonged to the same species -- despite the fact that body lice are bigger than head lice, cling to clothing instead of hair, and can transmit disease.

Since the early 2000s, Pittendrigh has worked with John M. Clark, a professor of environmental toxicology and chemistry at the University of Massachusetts, on the molecular biology and genomics of lice. Clark was a collaborator on the 2012 study, and the two have had "a long-term goal of trying to solve this question of why body lice transmit bacterial diseases and head lice don't," Pittendrigh said.

In the new study, Clark's group infected head and body lice with Bartonella quintana, the bacterium that causes trench fever. Pittendrigh's laboratory then looked at gene expression in each to see how the insects responded to the infection.

"Our experiments suggest that the head louse immune system is fairly effective in fighting off the bacteria that cause trench fever," Pittendrigh said. "However, the body lice don't seem to have as good an immune response."

The researchers discovered that several immune genes were regulated differently in head and body lice after infection with the bacteria, and the infection progressed further in body lice over time.

"By eight days post-infection, head lice had killed or contained the invading B. quintana, whereas the bacteria were still proliferating and spreading in body lice," the researchers reported.

The team cannot yet say why head and body louse immune responses differ from one another, but Pittendrigh hypothesizes that the body louse has a reason to be more tolerant of bacterial infection.

"Head and body lice have beneficial bacteria living inside them," he said. "These bacteria make vitamins that the lice need to grow and survive. Body lice tend to grow larger than head lice. It may be that a suppressed immune system allows body lice to grow more of the bacteria that make the vitamins they need, and they grow larger."

The body louse's dampened immune response would allow other invading bacteria, such as those that cause disease in humans, to also survive in its gut, he said.

"So body lice may grow bigger, but they also are more likely to get sick with the trench fever bacteria and pass the disease to humans," Pittendrigh said.


Story Source:

The above story is based on materials provided by University of Illinois at Urbana-Champaign. Note: Materials may be edited for content and length.


Journal Reference:

  1. Barry Pittendrigh et al. Differential Gene Expression in Laboratory Strains of Human Head and Body Lice When Challenged With Bartonella Quintana, a Pathogenic Bacterium. Molecular Biology, January 2014

Cite This Page:

University of Illinois at Urbana-Champaign. "One species, two outcomes: Team seeks source of body louse pathology." ScienceDaily. ScienceDaily, 10 January 2014. <www.sciencedaily.com/releases/2014/01/140110113616.htm>.
University of Illinois at Urbana-Champaign. (2014, January 10). One species, two outcomes: Team seeks source of body louse pathology. ScienceDaily. Retrieved August 20, 2014 from www.sciencedaily.com/releases/2014/01/140110113616.htm
University of Illinois at Urbana-Champaign. "One species, two outcomes: Team seeks source of body louse pathology." ScienceDaily. www.sciencedaily.com/releases/2014/01/140110113616.htm (accessed August 20, 2014).

Share This




More Plants & Animals News

Wednesday, August 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Awesome New Camouflage Sheet Was Inspired By Octopus Skin

Awesome New Camouflage Sheet Was Inspired By Octopus Skin

Newsy (Aug. 19, 2014) Scientists have developed a new device that mimics the way octopuses blend in with their surroundings to hide from dangerous predators. Video provided by Newsy
Powered by NewsLook.com
Disquieting Times for Malaysia's 'fish Listeners'

Disquieting Times for Malaysia's 'fish Listeners'

AFP (Aug. 19, 2014) Malaysia's last "fish listeners" -- practitioners of a dying local art of listening underwater to locate their quarry -- try to keep the ancient technique alive in the face of industrial trawling and the depletion of stocks. Duration: 02:29 Video provided by AFP
Powered by NewsLook.com
USDA Cracks Down On Imports From Foreign Puppy Mills

USDA Cracks Down On Imports From Foreign Puppy Mills

Newsy (Aug. 18, 2014) New USDA measures to regulate dog imports aim to crack down on buying dogs from overseas puppy mills. Video provided by Newsy
Powered by NewsLook.com
Bone Marrow Drug Regrows Hair In Some Alopecia Patients

Bone Marrow Drug Regrows Hair In Some Alopecia Patients

Newsy (Aug. 18, 2014) Researchers performed an experiment using an FDA-approved drug known as ruxolitinib. They found it to be successful in the majority of patients. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins